Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
boston blog main
boston top stories
3
×
fda
life sciences
national blog main
alexion pharmaceuticals
clinical trials
deals
national top stories
alnylam pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
boehringer ingelheim
complement system
crispr
cystic fibrosis
cystic fibrosis foundation
dicerna pharamceuticals
drugs
generalized myasthenia gravis
gilead sciences
hepatitis b
hepatitis b virus
hepatitis c
hereditary transthyretin amyloidosis
immune-mediated necrotizing myopathy
incivek
jeff leiden
kayldeco
matt emmens
messenger rna therapeutics
orkambi
patisiran
paul matteis
people
ra pharmaceuticals
rare disease drugs
rna interference
What
medicines
3
×
pharmaceuticals
3
×
disease
drug
pharma
alternative
autoimmune
candidate
caught
causing
cf
crisis
cystic
deal
developer
dicerna
expensive
eye
fibrosis
force
gene
helped
hepatitis
intended
jeff
lead
leiden
pay
potential
producing
profitable
protein
ra
research
roche
roles
shaped
stakes
steer
step
Language
unset
unknown
Current search:
medicines
×
biotech
×
pharmaceuticals
×
" boston top stories "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles